Patent · US Active

7-azaindoles and the use thereof as therapeutic agents

US7947705B2 · kind B2 · utility

0Cited by

7References

6Claims

0Family size

Assignee

Biotie Therapies, Inc. · US

Inventors

Norbert Höfgen · Radeberg, DE
Hildegard Kuss · Dresden, DE
Matthias Olbrich · Radebeul, DE
Ute Egerland · Radebeul, DE
Chris Rundfeldt · Coswig, DE
Karin Steinike · Radebeul, DE
Rudolf Schindler · Dresden, DE

Key dates

Filing date	Mar 6, 2007
Grant date	May 24, 2011
Priority date	—
Expiry date	Nov 5, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to substituted 7-azaindoles, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.